Los Altos, United States
Astellas Venture Management, the corporate venture capital branch of Astellas Pharma, a multinational pharmaceutical corporation headquartered in Japan, focuses on investing in emerging biotechnology companies. The origins of Astellas' venture capital operations can be traced back to the inception of Yamanouchi Venture Capital in 2000 and the establishment of Fujisawa Investments for Entrepreneurship in 1999. Currently, Astellas Venture Management manages four funds.
40
Total Investments
27
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Astellas Venture Management
Recent Investments (40)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Apr 2025 | |
| Series B | •••••• | Sep 2024 | |
| Series B | •••••• | Feb 2024 | |
| Series A | •••••• | Dec 2023 | |
| Series A | •••••• | Oct 2023 | |
•••• ••••
|
Seed | •••••• | Aug 2023 |
|
•••• ••••
|
Seed Round | •••••• | Feb 2023 |
|
•••• ••••
|
Series B | •••••• | Jan 2023 |
|
•••• ••••
|
Series C | •••••• | Nov 2022 |
|
•••• ••••
|
Series A | •••••• | Jun 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
